Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Dec 15, 2016

Sanofi Pasteur Continues Strengthening Safety Net Around Local Families in Need

Employee holiday drive echoes company’s holistic approach in supporting Monroe County Head Start and Pocono Alliance families
Dec 8, 2016

Sanofi and Regeneron Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA
Nov 21, 2016

Sanofi Receives FDA Approval of Soliqua™ 100/33 for the Treatment of Adults with Type 2 Diabetes
Nov 17, 2016

New Survey Finds Men in the U.S. Want to Take Charge of Their Own Health and Wellness

Data also Shows Men Consider Sexual Health to be an Important Priority
Nov 16, 2016

Sanofi and Regeneron Present Results from Phase 3 MONARCH Study of Investigational Sarilumab at American College of Rheumatology Annual Meeting

- In the MONARCH Study, Sarilumab Monotherapy Demonstrated Superiority Over Adalimumab Monotherapy in Adults with Active Rheumatoid Arthritis -
Nov 11, 2016

Sanofi and Regeneron to Present Data from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2016
Oct 28, 2016

Sanofi and Regeneron Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis
Oct 28, 2016

Sanofi Announces Strong Q3 2016 Results
- Photos 1
Oct 24, 2016

The Eradication of Poliomyelitis Is in Sight

2016 could be the year of the last case of wild poliomyelitis worldwide
Oct 5, 2016

New Survey Reveals the Widespread and Serious Impact of Moderate-to-Severe Atopic Dermatitis on People Living with the Disease

- U.S. adults report issues with sleep, ability to work and feelings of depression and anxiety -

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.